Immunovant, Inc. (IMVT) Tops Q3 EPS by 11c

Immunovant, Inc. (NASDAQ: IMVT) reported Q3 EPS of ($0.61), $0.11 better than the analyst estimate of ($0.72).

For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.

You May Also Be Interested In

• JPMorgan Upgrades Graphic Packaging Holding Company (GPK) to Overweight
• M&C Saatchi PLC (SAA:LN) PT Lowered to GBP1.62 at Deutsche Bank
• Amrize Ltd (AMRZ:SW) (AMRZ) PT Lowered to CHF46 at Deutsche Bank